A 45-year-old man with a 2-year history of a left main parotid gland (MPG) lesion, incidentally detected during maxillofacial computed tomography (CT) imaging for snoring, had a consultation at our institution for progressive enlargement of this tumor. Repeat CT evaluation showed a 2-cm tumor with homogeneous enhancement arising from the left deep parotid lobe (figure 1). CT also showed an additional 1-cm enhancing nodule at the right mid-cheek, anterior to the masseter muscle and medial to the parotid duct, suspicious for a lesion of the right accessory parotid gland (APG) (figure 1).
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A subsequent magnetic resonance imaging (MRI) exam confirmed the coexisting lesions of the right APG and left MPG (figure 2). The patient denied any trismus, hemoptysis, otalgia, dysphagia, facial weakness or twitching, facial numbness, sensation of aural pressure, or any other symptomatology related to the bilateral parotid involvement.
Tissue sampling and subsequent surgical resection of the bilateral synchronous lesions found a pleomorphic adenoma of the right APG and an epithelial/myoepithelial carcinoma of the left MPG. Postoperative 2-year clinical follow-up of this patient and 18F-fluorodeoxyglucose positron emission tomography/CT (18F-FDG PET/CT) imaging were negative for residual or recurrent head and neck malignancy.
The presented case is unique due to the coexisting lesions of different histologic types involving an MPG and a less frequently encountered contralateral APG. Concerning the left MPG, epithelial/myoepithelial carcinoma (EMC), previously known as clear-cell adenoma or adenomyoepithelioma, is a rare parotid gland tumor (1% of all parotid tumors). 1 It is presently considered as a low-grade malignant tumor with a propensity to local recurrence and a low potential for metastasis. Total resection is the best treatment for EMC. Concerning the APG, it is a distinct salivary gland located about 6 mm anterior to the MPG and linked to the masseter muscle by an extension of the masseteric fascia. [2] [3] [4] The pea-sized or bean-sized APG, encountered in 21% of individuals, is underneath the cheek and on top of the Stensen duct or parotid duct, along an imaginary line extending from the tragus to a point midway between the nasal ala and vermilion border of the lip. 2,3 APG has a 1 to 8% risk of harboring lesions, with 70% of them being benign and represented predominantly by pleomorphic adenoma. Lesions of the APG potentially have a higher rate of malignant involvement than the those of the MPG (26 to 50% versus 18.5%), possibly related to their combined mucinous and serous acinar composition, which is different from the predominantly serous constitution of the MPG. [4] [5] [6] Tumoral involvement of parotid glands is usually solitary. Multifocality of parotid gland lesions is rare; they may manifest unilaterally, bilaterally, synchronously, metachronously, bilaterally with multifocal lesions unilaterally or with bilateral multifocal lesions. 7, 8 The bilateral parotid gland tumors are mostly benign and are commonly represented by Warthin tumors. Instances of bilateral malignant disease, combined benign and malignant lesions, and bilateral tumors of different histologic types are less common. 7, 8 The synchronous presence of APG and MPG lesions is exceptionally rare and, to the best of our knowledge, has not been reported in the literature. 
